Hyperion Therapeutics Inc. (HPTX) said Friday that it has priced its follow-on offering of 2.88 million common shares at $20.75 per share, before underwriting discounts and commissions. All of the common stock is being offered by Hyperion.
In addition, the underwriters have a 30-day option to purchase up to an additional 431,250 shares of common stock from Hyperion to cover over-allotments, if any.
The offering is expected to close on March 13, 2013, subject to customary conditions.
Leerink Swann LLC and Cowen and Company, LLC are serving as joint book-running managers for the proposed offering. Needham & Company, LLC and JMP Securities LLC are acting as co-managers.
For comments and feedback: editorial@rttnews.com